9 Analysts Have This To Say About 3M

In the last three months, 9 analysts have published ratings on 3M MMM, offering a diverse range of perspectives from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 2 2 2 0
Last 30D 0 0 0 1 0
1M Ago 0 0 0 0 0
2M Ago 1 0 0 0 0
3M Ago 2 2 2 1 0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $148.44, a high estimate of $184.00, and a low estimate of $96.00. This current average reflects an increase of 15.63% from the previous average price target of $128.38.

price target chart

Understanding Analyst Ratings: A Comprehensive Breakdown

The analysis of recent analyst actions sheds light on the perception of 3M by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Matthew Swanson RBC Capital Lowers Underperform $96.00 $100.00
Damian Karas UBS Raises Buy $184.00 $130.00
Stephen Tusa JP Morgan Raises Overweight $165.00 $160.00
Deane Dray RBC Capital Raises Underperform $100.00 $99.00
Andrew Obin B of A Securities Raises Buy $160.00 $143.00
Julian Mitchell Barclays Raises Overweight $165.00 $160.00
Scott Davis Melius Research Announces Buy $180.00 -
Brett Linzey Mizuho Raises Neutral $146.00 $105.00
Joe O'Dea Wells Fargo Raises Equal-Weight $140.00 $130.00

Key Insights:

  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to 3M. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 3M compared to the broader market.
  • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of 3M's stock. This comparison reveals trends in analysts' expectations over time.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of 3M's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on 3M analyst ratings.

Delving into 3M's Background

3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.

Unraveling the Financial Story of 3M

Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.

Revenue Growth: 3M's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 0.38%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.

Net Margin: 3M's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 21.8% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): 3M's ROE stands out, surpassing industry averages. With an impressive ROE of 32.06%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): 3M's ROA excels beyond industry benchmarks, reaching 3.26%. This signifies efficient management of assets and strong financial health.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 2.97.

The Core of Analyst Ratings: What Every Investor Should Know

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!